BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 37452117)

  • 1. The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer.
    Liu Y; Liu Z; Yang Y; Cui J; Sun J; Liu Y
    Br J Cancer; 2023 Oct; 129(7):1041-1049. PubMed ID: 37452117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
    Ren X; Zhang L; Zhang Y; Li Z; Siemers N; Zhang Z
    Annu Rev Immunol; 2021 Apr; 39():583-609. PubMed ID: 33637019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology.
    Wienke J; Dierselhuis MP; Tytgat GAM; Künkele A; Nierkens S; Molenaar JJ
    Eur J Cancer; 2021 Feb; 144():123-150. PubMed ID: 33341446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Brain Tumours: Lessons from the Immune Microenvironment.
    Yao B; Delaidelli A; Vogel H; Sorensen PH
    Curr Oncol; 2023 May; 30(5):5024-5046. PubMed ID: 37232837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the tumour microenvironment in immunotherapy.
    Gasser S; Lim LHK; Cheung FSG
    Endocr Relat Cancer; 2017 Dec; 24(12):T283-T295. PubMed ID: 28754821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint.
    Verma NK; Wong BHS; Poh ZS; Udayakumar A; Verma R; Goh RKJ; Duggan SP; Shelat VG; Chandy KG; Grigoropoulos NF
    EBioMedicine; 2022 Sep; 83():104216. PubMed ID: 35986950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
    Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
    Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3
    Porcellato I; Silvestri S; Menchetti L; Recupero F; Mechelli L; Sforna M; Iussich S; Bongiovanni L; Lepri E; Brachelente C
    Vet Comp Oncol; 2020 Sep; 18(3):370-380. PubMed ID: 31750993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Luen SJ; Savas P; Fox SB; Salgado R; Loi S
    Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.
    Laumont CM; Banville AC; Gilardi M; Hollern DP; Nelson BH
    Nat Rev Cancer; 2022 Jul; 22(7):414-430. PubMed ID: 35393541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors.
    Takkenkamp TJ; Jalving M; Hoogwater FJH; Walenkamp AME
    Endocr Relat Cancer; 2020 Sep; 27(9):R329-R343. PubMed ID: 32590336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of tumour-infiltrating inflammatory cells in brain tumours: literature review.
    Bieńkowski M; Preusser M
    Curr Opin Neurol; 2015 Dec; 28(6):647-58. PubMed ID: 26402405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 16. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.
    Zhang Y; Zhang Z
    Cell Mol Immunol; 2020 Aug; 17(8):807-821. PubMed ID: 32612154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.
    Mezheyeuski A; Backman M; Mattsson J; Martín-Bernabé A; Larsson C; Hrynchyk I; Hammarström K; Ström S; Ekström J; Mauchanski S; Khelashvili S; Lindberg A; Agnarsdóttir M; Edqvist PH; Huvila J; Segersten U; Malmström PU; Botling J; Nodin B; Hedner C; Borg D; Brändstedt J; Sartor H; Leandersson K; Glimelius B; Portyanko A; Ponten F; Jirström K; Micke P; Sjöblom T
    EBioMedicine; 2023 Feb; 88():104452. PubMed ID: 36724681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating T Cell Immunity in Cancer: Achievements and Prospects.
    Zeng Z; Chew HY; Cruz JG; Leggatt GR; Wells JW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance.
    Takami H; Fukushima S; Aoki K; Satomi K; Narumi K; Hama N; Matsushita Y; Fukuoka K; Yamasaki K; Nakamura T; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Nakamura H; Sugiyama K; Tamura K; Maehara T; Nakada M; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kanemura Y; Kobayashi K; Nagane M; Kurozumi K; Yoshimoto K; Matsuda M; Matsumura A; Hirose Y; Tokuyama T; Kumabe T; Ueki K; Narita Y; Shibui S; Totoki Y; Shibata T; Nakazato Y; Nishikawa R; Matsutani M; Ichimura K;
    Neuropathol Appl Neurobiol; 2020 Feb; 46(2):111-124. PubMed ID: 31179566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination cancer immunotherapies tailored to the tumour microenvironment.
    Smyth MJ; Ngiow SF; Ribas A; Teng MW
    Nat Rev Clin Oncol; 2016 Mar; 13(3):143-58. PubMed ID: 26598942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.